• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin.

作者信息

Kim Ahwon, Keam Bhumsuk, Cheun Hyeon, Lee Soon Tae, Gook Hyung Seok, Han Moon Ku

机构信息

Department of Neurology, Seoul National University Hospital, Seoul, Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

出版信息

J Clin Neurol. 2019 Apr;15(2):259-261. doi: 10.3988/jcn.2019.15.2.259. Epub 2019 Mar 11.

DOI:10.3988/jcn.2019.15.2.259
PMID:30877699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6444136/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ae/6444136/b9179c52cd21/jcn-15-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ae/6444136/b9179c52cd21/jcn-15-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ae/6444136/b9179c52cd21/jcn-15-259-g001.jpg

相似文献

1
Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin.类固醇和静脉注射免疫球蛋白治疗免疫检查点抑制剂诱导的严重自身免疫性脑炎
J Clin Neurol. 2019 Apr;15(2):259-261. doi: 10.3988/jcn.2019.15.2.259. Epub 2019 Mar 11.
2
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.自身免疫性脑炎与转移性癌症联合免疫检查点抑制剂治疗的关联。
JAMA Neurol. 2016 Aug 1;73(8):928-33. doi: 10.1001/jamaneurol.2016.1399.
3
PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis.程序性死亡蛋白1（PD-1）检查点抑制剂相关自身免疫性脑炎
Case Rep Oncol. 2017 May 24;10(2):473-478. doi: 10.1159/000477162. eCollection 2017 May-Aug.
4
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review.纳武单抗相关的急性脱髓鞘性脑炎：一例报告及文献综述
Clin Med Res. 2019 Jun;17(1-2):29-33. doi: 10.3121/cmr.2019.1417.
5
Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis.免疫检查点抑制剂诱发的自身免疫性脑炎患者脑脊液中腺苷脱氨酶水平升高
Intern Med. 2019 Oct 1;58(19):2871-2874. doi: 10.2169/internalmedicine.2537-18. Epub 2019 Jun 27.
6
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.帕博利珠单抗诱导的晚期非小细胞肺癌患者自身免疫性脑炎：一例报告
Mol Clin Oncol. 2019 Feb;10(2):267-269. doi: 10.3892/mco.2018.1777. Epub 2018 Nov 27.
7
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.接受免疫检查点抑制剂治疗的黑色素瘤患者的血小板减少症。
J Immunother Cancer. 2017 Feb 21;5:8. doi: 10.1186/s40425-017-0210-0. eCollection 2017.
8
Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?纳武单抗治疗后免疫检查点抑制剂相关的中枢神经系统自身免疫性疾病（ICICAD）：药物性自身免疫性脑炎的一种新实体？
Eur J Cancer. 2017 Dec;87:205-208. doi: 10.1016/j.ejca.2017.09.026. Epub 2017 Oct 16.
9
Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange.免疫检查点抑制剂诱导的抗谷氨酸脱羧酶 65（Anti-GAD 65）边缘性脑炎对静脉免疫球蛋白和血浆置换有反应。
J Neurol. 2020 Apr;267(4):1023-1025. doi: 10.1007/s00415-019-09666-6. Epub 2019 Dec 13.
10
Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.纳武单抗诱发一名转移性肾细胞癌男性患者发生脑病：病例报告
J Med Case Rep. 2018 Sep 15;12(1):262. doi: 10.1186/s13256-018-1786-9.

引用本文的文献

1
Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis.阿替利珠单抗诱发的脑炎、无菌性脑膜炎或脑膜脑炎的临床特征、诊断、治疗及预后
Front Hum Neurosci. 2025 Jan 28;19:1443463. doi: 10.3389/fnhum.2025.1443463. eCollection 2025.
2
Patient with Atezolizumab-induced Encephalitis in Hepatocellular Carcinoma.肝细胞癌患者发生阿替利珠单抗诱导的脑炎。
Intern Med. 2025 Apr 15;64(8):1181-1187. doi: 10.2169/internalmedicine.4321-24. Epub 2024 Sep 11.
3
Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review.

本文引用的文献

1
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.那他珠单抗可能控制免疫检查点抑制剂诱发的边缘叶脑炎。
Neurol Neuroimmunol Neuroinflamm. 2018 Jan 11;5(2):e439. doi: 10.1212/NXI.0000000000000439. eCollection 2018 Mar.
2
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.重症监护病房中与阿替利珠单抗相关的脑炎：病例报告及文献综述
SAGE Open Med Case Rep. 2018 Aug 2;6:2050313X18792422. doi: 10.1177/2050313X18792422. eCollection 2018.
3
Neurologic complications of immune checkpoint inhibitors.
阿替利珠单抗和贝伐珠单抗治疗晚期肝细胞癌患者诱导性脑炎：病例报告及文献复习。
J Cancer Res Clin Oncol. 2024 Aug 24;150(8):397. doi: 10.1007/s00432-024-05918-9.
4
Immunotherapy toxicities: An SGO clinical practice statement.免疫治疗毒性：SGO临床实践声明
Gynecol Oncol. 2022 Jul;166(1):25-35. doi: 10.1016/j.ygyno.2022.05.003. Epub 2022 May 18.
5
Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review.阿替利珠单抗致肝癌患者脑炎：病例报告及文献复习。
Intern Med. 2022 Sep 1;61(17):2619-2623. doi: 10.2169/internalmedicine.8919-21. Epub 2022 Feb 19.
6
Overlapping NMDA-R and GFAP Antibody Autoimmune Encephalitis After Nivolumab Therapy.纳武单抗治疗后重叠的N-甲基-D-天冬氨酸受体（NMDA-R）和胶质纤维酸性蛋白（GFAP）抗体自身免疫性脑炎
Neurol Clin Pract. 2021 Dec;11(6):e913-e915. doi: 10.1212/CPJ.0000000000001008.
7
Neurologic Toxicities of Immunotherapy.免疫治疗的神经系统毒性。
Adv Exp Med Biol. 2021;1342:417-429. doi: 10.1007/978-3-030-79308-1_18.
8
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.广泛期小细胞肺癌使用度伐利尤单抗治疗相关的副肿瘤性脊髓炎。
Invest New Drugs. 2022 Feb;40(1):151-156. doi: 10.1007/s10637-021-01154-x. Epub 2021 Jul 21.
9
Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.一例转移性乳腺癌患者发生的阿替利珠单抗诱发的脑炎：病例报告及与检查点抑制剂相关的神经系统不良事件综述
Autops Case Rep. 2021 Apr 15;11:e2021261. doi: 10.4322/acr.2021.261.
10
Immune-Related Neurological Toxicities of PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.癌症患者中 PD-1/PD-L1 抑制剂的免疫相关神经系统毒性：系统评价和荟萃分析。
Front Immunol. 2020 Dec 18;11:595655. doi: 10.3389/fimmu.2020.595655. eCollection 2020.
免疫检查点抑制剂的神经并发症。
J Neurooncol. 2018 May;137(3):601-609. doi: 10.1007/s11060-018-2752-5. Epub 2018 Jan 13.
4
Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient.利妥昔单抗治疗一名小细胞肺癌患者中由纳武单抗加伊匹木单抗引起的脑炎
Ann Oncol. 2017 Sep 1;28(9):2318-2319. doi: 10.1093/annonc/mdx252.
5
Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers.阿替利珠单抗：一种用于癌症治疗的新型程序性死亡配体1（PD-L1）抑制剂，重点用于膀胱癌和非小细胞肺癌。
Drugs Today (Barc). 2017 Apr;53(4):217-237. doi: 10.1358/dot.2017.53.4.2589163.
6
Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.阿替利珠单抗诱发的转移性膀胱癌脑炎：一例报告及文献复习
Clin Genitourin Cancer. 2017 Oct;15(5):e847-e849. doi: 10.1016/j.clgc.2017.03.001. Epub 2017 Mar 16.
7
Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma.阿替利珠单抗在转移性尿路上皮癌中的临床药代动力学和药效学
Clin Pharmacol Ther. 2017 Aug;102(2):305-312. doi: 10.1002/cpt.587. Epub 2017 Jun 9.
8
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.自身免疫性脑炎与转移性癌症联合免疫检查点抑制剂治疗的关联。
JAMA Neurol. 2016 Aug 1;73(8):928-33. doi: 10.1001/jamaneurol.2016.1399.
9
Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma.纳武利尤单抗治疗黑色素瘤后的亚急性中枢神经系统脱髓鞘。
Cancer Immunol Res. 2015 Dec;3(12):1299-302. doi: 10.1158/2326-6066.CIR-15-0141. Epub 2015 Sep 29.
10
Paraneoplastic syndromes in patients with urological malignancies.泌尿系统恶性肿瘤患者的副肿瘤综合征
Urol Int. 2009;83(1):1-11. doi: 10.1159/000224860. Epub 2009 Jul 27.